Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. usa california
  4. biopsy testing
Show results for
Products
Services
Applications

Companies


Refine by
Locations
Back to All Locations

  • USA
  • California
Brands

  • biocept
  • guidance
  • selectmdx
Applications

  • Diagnostic Solutions for Lung Cancer
  • Liquid Biopsy Solutions for Breast Cancer
  • Diagnostic Solutions for Colorectal Cancer
  • Actionable Molecular Diagnostic System for Physicians

Biopsy Testing Equipment Supplied In Usa California

8 equipment items found
In CaliforniaAvailable In CaliforniaNear California

Biocept - Model NGS - Next-Gen Sequencing Lung Panel - Liquid Biopsy Biomarker

Biocept - Model NGS - Next-Gen Sequencing Lung Panel - Liquid Biopsy Biomarker

Manufactured by:Biocept    based inSan Diego, CALIFORNIA (USA)
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support ...
CONTACT SUPPLIER

Biocept - Model NGS - Next-Gen Sequencing Breast Panel  - Liquid Biopsy Biomarker

Biocept - Model NGS - Next-Gen Sequencing Breast Panel - Liquid Biopsy Biomarker

Manufactured by:Biocept    based inSan Diego, CALIFORNIA (USA)
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support ...
CONTACT SUPPLIER

Guidance - Pre Prostate Biopsy Rectal Swab (GPPBRS) Test

Guidance - Pre Prostate Biopsy Rectal Swab (GPPBRS) Test

Manufactured by:Pathnostics   based inIrvine, CALIFORNIA (USA)
The Guidance Pre Prostate Biopsy Rectal Swab (GPPBRS) test identifies antimicrobials that may be used prophylactically by using our patented Pooled-Antimicrobial Susceptibility Testing technology to determine the presence or absence of resistance genes. When an appropriate antimicrobial is used before and after the prostate ...
CONTACT SUPPLIER

Model Guardant Reveal - Residual Disease Detection And Recurrence Monitoring

Model Guardant Reveal - Residual Disease Detection And Recurrence Monitoring

Manufactured by:Guardant Health, Inc.   based inRedwood City, CALIFORNIA (USA)
Our Guardant Reveal™ test is the first blood-only test that detects residual and recurrent disease in two weeks, without the need for a tissue biopsy. The test detects circulating tumor DNA (ctDNA) in blood after surgery to identify patients with residual disease who may benefit most from adjuvant therapy. ...
CONTACT SUPPLIER

Model Decipher - Prostate Genomic Classifier

Model Decipher - Prostate Genomic Classifier

Manufactured by:Veracyte, Inc.   based inSouth San Francisco, CALIFORNIA (USA)
Providing clarity and confidence in treatment planning. The Decipher Prostate (Decipher Prostate Biopsy and Decipher Prostate RP) genomic classifier is a 22-gene, whole-transcriptome-developed test designed to help inform treatment decisions for men with localized prostate cancer at initial diagnosis and after surgical removal of the prostate. The ...
CONTACT SUPPLIER

Moving Prenatal Screening and Liquid Biopsy Forward

Moving Prenatal Screening and Liquid Biopsy Forward

by:BillionToOne Inc.   based inMenlo Park, CALIFORNIA (USA)
Shifting the Paradigm of Prenatal Screening: The name of our non-invasive prenatal test (NIPT) is appropriately called “UNITY” as it brings together fetal screening for aneuploidies and recessive conditions. It also represents uniting pregnant patients in more equitable ...
CONTACT SUPPLIER

Molecular Counting Technology

Molecular Counting Technology

by:BillionToOne Inc.   based inMenlo Park, CALIFORNIA (USA)
Our molecular counting platform can help quantify nearly undetectable DNA changes, unlocking improvements to non-invasive prenatal screening and liquid ...
CONTACT SUPPLIER

SelectMDx - Actionable Molecular Diagnostic System for Prostate Cancer

SelectMDx - Actionable Molecular Diagnostic System for Prostate Cancer

Manufactured by:MDxHealth   based inIrvine, CALIFORNIA (USA)
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA cancer-related biomarkers (HOXC6 and DLX1).1 The test provides binary results that, when ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT